Page 99 - Cellular Imaging in Regenerative Medicine, Cancer and Osteoarthritis
P. 99

                                65. Garbin V, Dollet B, Overvelde M, Cojoc D, Di Fabrizio E, van Wijngaarden L, et al. History force on coated microbubbles propelled by ultrasound. Phys Fluids. 2009;21(9):092003.
66. Dayton PA, Morgan KE, Klibanov AL, Brandenburger GH, Ferrara KW. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 1999;46(1):220-32.
67. van Tiel ST, Wielopolski PA, Houston GC, Krestin GP, Bernsen MR. Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cells. Contrast Media Mol Imaging. 2010;5(5):247-57.
68. Green DR. Apoptotic pathways: ten minutes to dead. Cell. 2005;121(5):671-4.
69. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495-516.
70. Feril LB, Jr., Kondo T, Zhao QL, Ogawa R, Tachibana K, Kudo N, et al. Enhancement of ultrasound- induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol. 2003;29(2):331-7.
71. Zhong W, Sit WH, Wan JM, Yu AC. Sonoporation induces apoptosis and cell cycle arrest in human promyelocytic leukemia cells. Ultrasound Med Biol. 2011;37(12):2149-59.
72. Miller DL, Dou C. Induction of apoptosis in sonoporation and ultrasonic gene transfer. Ultrasound Med Biol. 2009;35(1):144-54.
73. Fan Z, Liu H, Mayer M, Deng CX. Spatiotemporally controlled single cell sonoporation. Proc Natl Acad Sci USA. 2012;109(41):16486-91.
74. Afadzi M, Strand SP, Nilssen EA, Masoy SE, Johansen TF, Hansen R, et al. Mechanisms of the ultrasound-mediated intracellular delivery of liposomes and dextrans. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60(1):21-33.
75. Zeghimi A, Escoffre JM, Bouakaz A. Role of endocytosis in sonoporation-mediated membrane permeabilization and uptake of small molecules: a electron microscopy study. Phys Biol. 2015;12(6):066007.
76. Yang F, Gu N, Chen D, Xi X, Zhang D, Li Y, et al. Experimental study on cell self-sealing during sonoporation. J Control Release. 2008;131(3):205-10.
77. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg. 2011;1(1):35-40.
78. Yudina A, Lepetit-Coiffe M, Moonen CT. Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement. Mol Imaging Biol. 2011;13(2):239-49.
79. Lammertink B, Deckers R, Storm G, Moonen C, Bos C. Duration of ultrasound-mediated enhanced plasma membrane permeability. Int J Pharm. 2015;482(1-2):92-8.
80. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000;156(4):1363-80.
81. Clarke PR, Hill CR. Biological action of ultrasound in relation to the cell cycle. Exp Cell Res. 1969;58(2):443-4.
82. Hrazdira I, Skorpikova J, Dolnikova M. Ultrasonically induced alterations of cultured tumour cells. Eur J Ultrasound. 1998;8(1):43-9.
83. Fu YK, Miller MW, Lange CS, Griffiths TD, Kaufman GE. Ultrasound lethality to synchronous and asynchronous Chinese hamster V-79 cells. Ultrasound Med Biol. 1980;6(1):39-46.
84. Abou-Elkacem L, Bachawal SV, Willmann JK. Ultrasound molecular imaging: Moving toward clinical translation. Eur J Radiol. 2015;84(9):1685-93.
85. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today. 1994;15(10):490-5.
86. Smeenge M, Tranquart F, Mannaerts CK, de Reijke TM, van de Vijver MJ, Laguna MP, et al. First- in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study. Invest Radiol. 2017;52(7):419- 27.
87. Willmann JK, Bonomo L, Carla Testa A, Rinaldi P, Rindi G, Valluru KS, et al. Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results. J Clin Oncol. 2017;35(19):2133-40.
SPIO cell labeling using ultrasound
97
4
 








































































   97   98   99   100   101